A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases.

A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. Abstract Text:

Weiwei Li,Jacqueline L Blankman,Benjamin F Cravatt,

A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. Publishing Authors By Initials

W Li,JL Blankman,BF Cravatt,

For similar biological sciences: biochemistry: proteomics research abstracts see: biological sciences: biochemistry: proteomics research

PUBMED ID PMID:

MEDLINE DATE:

A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Journal of the American Chemical Society

VOLUME: 129

Page Numbers: 9594-5

Journal Abbreviation: J. Am. Chem. Soc.

ISSN: 0002-7863

DAY: 13

MONTH: 07

YEAR: 2007

A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7503056

A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. Keywords Mesh Terms:

KEYWORDS: Proteomics

MESH TERMS: methods

Chemical & Substance for Abstract: A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. Information

Substance Name: Hydrolases

Registry Number: EC 3.-

Grant and Affiliation Information for A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases.

AFFILIATION: The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.

Country: United States

AGENCY: United States NCI

GRANT: CA087660

ACRONYM: CA

MEDLINETA: J Am Chem Soc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases Related Publications

• A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol.
• A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases.
• A second fatty acid amide hydrolase with variable distribution among placental mammals.
• A tandem orthogonal proteolysis strategy for high-content chemical proteomics.
• Activity-based probes for proteomic profiling of histone deacetylase complexes.
• Analytical platforms for activity-based protein profiling--exploiting the versatility of chemistry for functional proteomics.
• Anandamide Biosynthesis Catalyzed by the Phosphodiesterase GDE1 and Detection of Glycerophospho-N-acyl Ethanolamine Precursors in Mouse Brain.
• Chemical proteomic probes for profiling cytochrome p450 activities and drug interactions in vivo.
• Chemoselective probes for metabolite enrichment and profiling.
• Disparate proteome reactivity profiles of carbon electrophiles.
• Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway.
• Enrichment tags for enhanced-resolution profiling of the polar metabolome.
• Enzymatic pathways that regulate endocannabinoid signaling in the nervous system.
• Global mapping of the topography and magnitude of proteolytic events in apoptosis.
• Mechanism-based profiling of enzyme families.
• Mechanistic and structural requirements for active site labeling of phosphoglycerate mutase by spiroepoxides.
• Microarray platform for profiling enzyme activities in complex proteomes.
• Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity.
• Optimization of activity-based probes for proteomic profiling of histone deacetylase complexes.
• Substrate mimicry in an activity-based probe that targets the nitrilase family of enzymes.
• Targeted disruption of the PME-1 gene causes loss of demethylated PP2A and perinatal lethality in mice.
• The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases.